Search results
Results From The WOW.Com Content Network
Total equity. US$699.14 million (2019) Number of employees. 570 (June 30, 2020) Website. acadia .com. Footnotes / references. [1] Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Sorrento Valley, San Diego, California.
(Reuters) -Culper Research has taken a short position on Acadia Pharmaceuticals' stock, it said on Thursday, sending the drugmaker's shares down as much as 8%. Acadia's drug, trofinetide, to treat ...
ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year ... including $230,000 in stock-based compensation, from $4.4 million for the comparable quarter of 2011, including ...
(Reuters) -Acadia Pharmaceuticals said on Monday it does not plan to conduct further clinical trials of its antipsychotic drug, pimavanserin, after it failed to improve negative symptoms of ...
ACADIA Pharmaceuticals was on fire yesterday, up 24% after presenting data for its antipsychotic pimavanserin at the American Academy of Neurology annual meeting. The data looked good.
Shares of ACADIA Pharmaceuticals shot through the roof today, up 30% as of this filming. In the video below, Fool health-care analyst David Williamson discusses news of some great phase 3 trial ...
AC-262536 is a drug developed by Acadia Pharmaceuticals which acts as a selective androgen receptor modulator (SARM). Chemically it possesses endo-exo isomerism, with the endo form being the active form. It acts as a partial agonist for the androgen receptor with a K i of 5 nM, and no significant affinity for any other receptors tested.
For premium support please call: 800-290-4726 more ways to reach us